Division of Biomedical Technology548
Division of Biomedical Technology aims to improve quality of human life through the convergence of basic, applied life science and biomaterial technology development. We will conduct research on disease-related mechanisms and therapeutic targets based on the companion indicators, and develop molecular and non-molecular diagnostic indicators including drug-susceptibility. Functional biomaterials and bioplastics using biocompatible polymers are under development and a variety of microplastic models are studied to test its ecological and human health hazards. We aim to contribute to the improvement of national health and quality of life as part of the national science and technology policy related to biomedical research.
DGIST Division of Biomedical Technology Homepage
DGIST Division of Biomedical Technology Homepage
Subject
- SPECTROSCOPY 12
- DRUG-DELIVERY 11
- INFLAMMATION 11
- DISEASE 10
- DELIVERY 9
- DYNAMICS 9
- IN-VITRO 9
- IN-VIVO 9
- PHOTOLUMINESCENCE 9
- Polymers 9
Date issued
- 2020 - 2026 183
- 2010 - 2019 182
- 2006 - 2009 24
Co-Author(s)
Related Keyword
Recent Submissions
- Multi-modality image fusion model of AFM-derived extracellular vesicles for NSCLC subtype diagnosis
- 3차원 자기장 측정 장치 및 자기장 매핑 시스템
- 메플로퀸 또는 이의 유도체를 포함하는 신장 질환의 치료용 조성물
- 메틱센 또는 이의 약제학적으로 허용 가능한 염을 포함하는 신장 질환의 치료용 조성물
- A Steerable and Expandable Magnetic Aspiration Catheter for Enhanced Aspiration Thrombectomy
